Seek Returns logo

CI vs. TMO: A Head-to-Head Stock Comparison

Updated on

Here’s a clear look at CI and TMO, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.

Company Profile

SymbolCITMO
Company NameThe Cigna GroupThermo Fisher Scientific Inc.
CountryUnited StatesUnited States
GICS SectorHealth CareHealth Care
GICS IndustryHealth Care Providers & ServicesLife Sciences Tools & Services
Market Capitalization81.30 billion USD186.85 billion USD
ExchangeNYSENYSE
Listing DateMarch 31, 1982March 17, 1980
Security TypeCommon StockCommon Stock

Historical Performance

This chart compares the performance of CI and TMO by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.

CI vs. TMO: Growth of a $10,000 investment over the past one year.

Historical Performance at a Glance

SymbolCITMO
5-Day Price Return4.90%2.01%
13-Week Price Return-5.40%19.54%
26-Week Price Return1.58%-7.10%
52-Week Price Return-11.03%-18.56%
Month-to-Date Return13.91%5.80%
Year-to-Date Return10.30%-4.89%
10-Day Avg. Volume1.80M2.06M
3-Month Avg. Volume1.86M2.79M
3-Month Volatility30.51%33.49%
Beta0.470.78

Profitability

Return on Equity (TTM)

CI

12.27%

Health Care Providers & Services Industry

Max
26.03%
Q3
13.74%
Median
8.26%
Q1
4.13%
Min
-3.62%

CI’s Return on Equity of 12.27% is on par with the norm for the Health Care Providers & Services industry, indicating its profitability relative to shareholder equity is typical for the sector.

TMO

13.27%

Life Sciences Tools & Services Industry

Max
19.96%
Q3
11.55%
Median
6.22%
Q1
3.86%
Min
-6.95%

In the upper quartile for the Life Sciences Tools & Services industry, TMO’s Return on Equity of 13.27% signals a highly effective use of shareholder capital to drive profitability compared to most of its peers.

CI vs. TMO: A comparison of their Return on Equity (TTM) against their respective Health Care Providers & Services and Life Sciences Tools & Services industry benchmarks.

Net Profit Margin (TTM)

CI

1.92%

Health Care Providers & Services Industry

Max
12.40%
Q3
5.93%
Median
1.96%
Q1
0.93%
Min
-6.10%

CI’s Net Profit Margin of 1.92% is aligned with the median group of its peers in the Health Care Providers & Services industry. This indicates its ability to convert revenue into profit is typical for the sector.

TMO

15.23%

Life Sciences Tools & Services Industry

Max
27.28%
Q3
16.17%
Median
7.24%
Q1
3.00%
Min
-3.05%

TMO’s Net Profit Margin of 15.23% is aligned with the median group of its peers in the Life Sciences Tools & Services industry. This indicates its ability to convert revenue into profit is typical for the sector.

CI vs. TMO: A comparison of their Net Profit Margin (TTM) against their respective Health Care Providers & Services and Life Sciences Tools & Services industry benchmarks.

Operating Profit Margin (TTM)

CI

3.41%

Health Care Providers & Services Industry

Max
19.05%
Q3
10.21%
Median
4.22%
Q1
1.98%
Min
-4.27%

CI’s Operating Profit Margin of 3.41% is around the midpoint for the Health Care Providers & Services industry, indicating that its efficiency in managing core business operations is typical for the sector.

TMO

17.13%

Life Sciences Tools & Services Industry

Max
33.15%
Q3
19.34%
Median
13.02%
Q1
8.05%
Min
-4.38%

TMO’s Operating Profit Margin of 17.13% is around the midpoint for the Life Sciences Tools & Services industry, indicating that its efficiency in managing core business operations is typical for the sector.

CI vs. TMO: A comparison of their Operating Profit Margin (TTM) against their respective Health Care Providers & Services and Life Sciences Tools & Services industry benchmarks.

Profitability at a Glance

SymbolCITMO
Return on Equity (TTM)12.27%13.27%
Return on Assets (TTM)3.26%6.62%
Net Profit Margin (TTM)1.92%15.23%
Operating Profit Margin (TTM)3.41%17.13%
Gross Profit Margin (TTM)9.86%41.34%

Financial Strength

Current Ratio (MRQ)

CI

0.79

Health Care Providers & Services Industry

Max
2.01
Q3
1.49
Median
1.30
Q1
0.94
Min
0.17

CI’s Current Ratio of 0.79 falls into the lower quartile for the Health Care Providers & Services industry. This indicates a tighter liquidity situation and a more constrained capacity to handle short-term debt than many of its competitors.

TMO

1.93

Life Sciences Tools & Services Industry

Max
4.76
Q3
2.77
Median
1.85
Q1
1.40
Min
0.43

TMO’s Current Ratio of 1.93 aligns with the median group of the Life Sciences Tools & Services industry, indicating that its short-term liquidity is in line with its sector peers.

CI vs. TMO: A comparison of their Current Ratio (MRQ) against their respective Health Care Providers & Services and Life Sciences Tools & Services industry benchmarks.

Debt-to-Equity Ratio (MRQ)

CI

0.77

Health Care Providers & Services Industry

Max
2.17
Q3
1.18
Median
0.74
Q1
0.45
Min
0.00

CI’s Debt-to-Equity Ratio of 0.77 is typical for the Health Care Providers & Services industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.

TMO

0.70

Life Sciences Tools & Services Industry

Max
1.75
Q3
0.83
Median
0.41
Q1
0.18
Min
0.00

TMO’s Debt-to-Equity Ratio of 0.70 is typical for the Life Sciences Tools & Services industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.

CI vs. TMO: A comparison of their Debt-to-Equity Ratio (MRQ) against their respective Health Care Providers & Services and Life Sciences Tools & Services industry benchmarks.

Interest Coverage Ratio (TTM)

CI

2.32

Health Care Providers & Services Industry

Max
14.47
Q3
7.15
Median
5.45
Q1
2.04
Min
-4.44

CI’s Interest Coverage Ratio of 2.32 is positioned comfortably within the norm for the Health Care Providers & Services industry, indicating a standard and healthy capacity to cover its interest payments.

TMO

23.55

Life Sciences Tools & Services Industry

Max
29.61
Q3
23.24
Median
6.07
Q1
2.18
Min
-14.08

TMO’s Interest Coverage Ratio of 23.55 is in the upper quartile for the Life Sciences Tools & Services industry, signifying a strong and healthy capacity to meet its interest payments from operating profits.

CI vs. TMO: A comparison of their Interest Coverage Ratio (TTM) against their respective Health Care Providers & Services and Life Sciences Tools & Services industry benchmarks.

Financial Strength at a Glance

SymbolCITMO
Current Ratio (MRQ)0.791.93
Quick Ratio (MRQ)0.681.50
Debt-to-Equity Ratio (MRQ)0.770.70
Interest Coverage Ratio (TTM)2.3223.55

Growth

Revenue Growth

CI vs. TMO: A side-by-side comparison of their Revenue Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

EPS Growth

CI vs. TMO: A side-by-side comparison of their EPS Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

Dividend

Dividend Yield (TTM)

CI

1.97%

Health Care Providers & Services Industry

Max
5.38%
Q3
2.22%
Median
0.55%
Q1
0.00%
Min
0.00%

CI’s Dividend Yield of 1.97% is consistent with its peers in the Health Care Providers & Services industry, providing a dividend return that is standard for its sector.

TMO

0.33%

Life Sciences Tools & Services Industry

Max
1.80%
Q3
0.78%
Median
0.37%
Q1
0.00%
Min
0.00%

TMO’s Dividend Yield of 0.33% is consistent with its peers in the Life Sciences Tools & Services industry, providing a dividend return that is standard for its sector.

CI vs. TMO: A comparison of their Dividend Yield (TTM) against their respective Health Care Providers & Services and Life Sciences Tools & Services industry benchmarks.

Dividend Payout Ratio (TTM)

CI

31.63%

Health Care Providers & Services Industry

Max
186.69%
Q3
74.82%
Median
26.76%
Q1
0.00%
Min
0.00%

CI’s Dividend Payout Ratio of 31.63% is within the typical range for the Health Care Providers & Services industry, suggesting a balanced approach between shareholder payouts and company reinvestment.

TMO

9.27%

Life Sciences Tools & Services Industry

Max
156.00%
Q3
65.73%
Median
23.81%
Q1
0.00%
Min
0.00%

TMO’s Dividend Payout Ratio of 9.27% is within the typical range for the Life Sciences Tools & Services industry, suggesting a balanced approach between shareholder payouts and company reinvestment.

CI vs. TMO: A comparison of their Dividend Payout Ratio (TTM) against their respective Health Care Providers & Services and Life Sciences Tools & Services industry benchmarks.

Dividend at a Glance

SymbolCITMO
Dividend Yield (TTM)1.97%0.33%
Dividend Payout Ratio (TTM)31.63%9.27%

Valuation

Price-to-Earnings Ratio (TTM)

CI

16.09

Health Care Providers & Services Industry

Max
55.89
Q3
30.85
Median
21.17
Q1
12.63
Min
0.00

CI’s P/E Ratio of 16.09 is within the middle range for the Health Care Providers & Services industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.

TMO

28.41

Life Sciences Tools & Services Industry

Max
117.96
Q3
65.59
Median
37.26
Q1
27.51
Min
1.73

TMO’s P/E Ratio of 28.41 is within the middle range for the Life Sciences Tools & Services industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.

CI vs. TMO: A comparison of their Price-to-Earnings Ratio (TTM) against their respective Health Care Providers & Services and Life Sciences Tools & Services industry benchmarks.

Price-to-Sales Ratio (TTM)

CI

0.31

Health Care Providers & Services Industry

Max
3.10
Q3
1.74
Median
0.67
Q1
0.24
Min
0.00

CI’s P/S Ratio of 0.31 aligns with the market consensus for the Health Care Providers & Services industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.

TMO

4.33

Life Sciences Tools & Services Industry

Max
12.46
Q3
6.70
Median
4.24
Q1
2.68
Min
0.73

TMO’s P/S Ratio of 4.33 aligns with the market consensus for the Life Sciences Tools & Services industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.

CI vs. TMO: A comparison of their Price-to-Sales Ratio (TTM) against their respective Health Care Providers & Services and Life Sciences Tools & Services industry benchmarks.

Price-to-Book Ratio (MRQ)

CI

2.20

Health Care Providers & Services Industry

Max
7.61
Q3
4.32
Median
2.53
Q1
1.14
Min
0.77

CI’s P/B Ratio of 2.20 is within the conventional range for the Health Care Providers & Services industry. This shows a balanced market view, where the stock’s price is neither at a significant premium nor a discount to the book value of its peers.

TMO

3.03

Life Sciences Tools & Services Industry

Max
7.99
Q3
4.69
Median
3.30
Q1
1.88
Min
1.02

TMO’s P/B Ratio of 3.03 is within the conventional range for the Life Sciences Tools & Services industry. This shows a balanced market view, where the stock’s price is neither at a significant premium nor a discount to the book value of its peers.

CI vs. TMO: A comparison of their Price-to-Book Ratio (MRQ) against their respective Health Care Providers & Services and Life Sciences Tools & Services industry benchmarks.

Valuation at a Glance

SymbolCITMO
Price-to-Earnings Ratio (TTM)16.0928.41
Price-to-Sales Ratio (TTM)0.314.33
Price-to-Book Ratio (MRQ)2.203.03
Price-to-Free Cash Flow Ratio (TTM)12.4930.32